TD2 Trademark

Trademark Overview

On Monday, October 27, 2003, a trademark application was filed for TD2 with the United States Patent and Trademark Office. The USPTO has given the TD2 trademark a serial number of 78318916. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, March 11, 2025. This trademark is owned by The Translational Genomics Research Institute. The TD2 trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services, medical and scientific research consultation services in the field of clinical trials
td2

General Information

Serial Number78318916
Word MarkTD2
Filing DateMonday, October 27, 2003
Status800 - REGISTERED AND RENEWED
Status DateTuesday, March 11, 2025
Registration Number2920122
Registration DateTuesday, January 18, 2005
Mark Drawing1 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 13, 2004

Trademark Statements

Goods and ServicesPharmaceutical drug development services, medical and scientific research consultation services in the field of clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 20, 2003
Primary Code042
First Use Anywhere DateSunday, March 28, 2004
First Use In Commerce DateSunday, March 28, 2004

Trademark Owner History

Party NameTRANSLATIONAL DRUG DEVELOPMENT, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressSCOTTSDALE, AZ 85259
Party NameThe Translational Genomics Research Institute
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressPhoenix, AZ 85004
Party NameThe Translational Genomics Research Institute
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressPhoenix, AZ 85004
Party NameThe Translational Genomics Research Institute
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressPhoenix, AZ 85004

Trademark Events

Event DateEvent Description
Friday, May 7, 2004ASSIGNED TO EXAMINER
Thursday, November 20, 2003NEW APPLICATION ENTERED
Monday, November 24, 2003TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, November 17, 2004LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, May 7, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 23, 2004NOTICE OF PUBLICATION
Tuesday, July 13, 2004PUBLISHED FOR OPPOSITION
Tuesday, October 5, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Thursday, October 28, 2004TEAS STATEMENT OF USE RECEIVED
Thursday, October 28, 2004USE AMENDMENT FILED
Wednesday, November 10, 2004STATEMENT OF USE PROCESSING COMPLETE
Wednesday, November 10, 2004ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, November 15, 2004ASSIGNED TO LIE
Tuesday, June 24, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 18, 2005REGISTERED-PRINCIPAL REGISTER
Tuesday, November 16, 2010TEAS SECTION 8 & 15 RECEIVED
Saturday, December 4, 2010CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, December 4, 2010REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, March 6, 2013ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, January 8, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, June 19, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 19, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 24, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 4, 2024TEAS SECTION 8 & 9 RECEIVED
Tuesday, March 11, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, March 11, 2025REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Tuesday, March 11, 2025REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, March 11, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Monday, July 14, 2014TEAS SECTION 8 & 9 RECEIVED
Tuesday, July 29, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, July 29, 2014REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, July 29, 2014REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, July 29, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, January 18, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

services field consultation clinical trials research scientific drug development medical